Bangladesh Measles Outbreak: 528 Children Dead, Widespread Transmission

Bangladesh is currently battling a severe and rapidly escalating measles outbreak, which has resulted in a tragic loss of life, predominantly among young children. As of May 24, 2026, the Directorate General of Health Services (DGHS) reported a total of 528 deaths linked to measles and its complications. This grim toll includes 16 fatalities recorded in the 24 hours leading up to Sunday morning, May 24th. Of the total deaths, 86 are confirmed measles cases, while 442 are individuals who died with measles-like symptoms. The outbreak, which commenced in mid-March 2026, has seen a significant surge in both suspected and confirmed cases across the nation. Official figures indicate that since March 15th, 2026, over 63,000 suspected measles cases have been identified, with 8,622 laboratory-confirmed infections reported. The scale of this health crisis is further underscored by the fact that over 50,500 children have been admitted to hospitals with measles symptoms during this period, though more than 46,000 have been discharged after treatment. The highly contagious disease has spread extensively, affecting 58 out of Bangladesh's 64 districts, indicating widespread national transmission. The capital, Dhaka Division, has been particularly hard-hit, accounting for a substantial number of deaths and infections, highlighting the vulnerability of densely populated urban areas and informal settlements. Children under the age of five constitute the majority of those affected, with a particularly high incidence among infants under nine months who are often too young for routine immunization or have not completed their vaccination schedule. Several factors have contributed to the severity of this outbreak. Reports from UNICEF and other health organizations indicate a critical decline in routine immunization coverage, exacerbated by a nationwide shortage of the Measles-Rubella (MR) vaccine between 2024 and 2025. This vaccine scarcity, combined with the absence of regular nationwide supplementary MR campaigns since 2020 and a shift in government focus during the COVID-19 pandemic and an interim administration, created significant immunity gaps within the population, leaving a large cohort of children unprotected. In response to the escalating crisis, the Bangladeshi government, with crucial support from UNICEF, WHO, and GAVI, initiated emergency mass vaccination campaigns. These campaigns, launched in phases starting from April 5, 2026, initially targeted high-risk areas and later expanded nationwide to cover millions of children aged between 6 and 59 months, regardless of their prior vaccination status. Beyond vaccination, authorities have deployed rapid response teams, intensified disease surveillance, and increased the distribution of Vitamin A to help mitigate complications associated with measles. However, the healthcare infrastructure in Bangladesh is under immense strain. Hospitals, particularly in Dhaka, are reportedly overwhelmed with patients, leading to overcrowding and a critical shortage of intensive care beds. Many patients, especially children, are receiving treatment on hospital floors due to the lack of available beds. International health bodies have expressed grave concerns about the outbreak's implications. The World Health Organization (WHO) has specifically warned of a significant risk of the disease spreading to neighboring countries like Myanmar and India, given the highly contagious nature of measles and cross-border movements. For India, this poses a considerable public health concern, necessitating heightened surveillance and preparedness to prevent a similar outbreak. The current situation in Bangladesh serves as a stark reminder of the critical importance of robust and consistent immunization programs in maintaining public health security, both nationally and regionally.

Frequently Asked Questions

Read Full Story on Quick Digest